Safe medical treatment in Palliative care - Pharmaceutical analysis of palliativ care medication process
Not Applicable
Recruiting
- Conditions
- Z51.5Palliative care
- Registration Number
- DRKS00013591
- Lead Sponsor
- Klinik und Poliklinik für PalliativmedizinKlinikum der Universtität München
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
incurable disease (malignant or non-malignant)
- >18 years
- inpatient (St. Josefs-Hospital Wiesbaden oder Helios HSK Wiesbaden)
- communication (german/english)
- Statement of agreement
Exclusion Criteria
Person who are unable to give their consent
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method drug-related problems (inpatient, outpatient)<br>Classification drug related problems (PCNE V8.1)
- Secondary Outcome Measures
Name Time Method - Deviations between inpatient medication and medication 7 days after discharge from the hospital<br>- Interactions: inpatient (day 2, last day), 7 days after discharge from the hospital <br>- pharmacist visits patient at home 7 days after discharge from the hospital<br>- unplaned admission in the hospital<br>- Change in clinical symptoms